obesity-995x60.png
FEATURED ARTICLES
Who Is Responsible When AI Helps Write The Consent Form?
AI is reshaping consent materials, but accuracy, oversight, and transparency remain essential. As guidance evolves, organizations must balance innovation with accountability to protect participants.
-
Helus Shares Experience Studying Adjunctive Psychedelic For Major Depressive Disorder
Helus Pharma CMO Amir Inamdar discusses the strategic rationale behind its Phase 3 trial for major depressive disorder, including its adjunctive-treatment approach, patient population selection, and endpoint strategy.
-
Understanding And Preserving Data Flow Integrity In AI-Assisted Clinical Trials
Learn from ex-FDA and ELIQUENT consultant Dawn Wydner, Ph.D.., how treating data integrity as an end-to-end clinical information flow issue, rather than a database-only concern, is essential to managing AI-related risk.
-
Electronic Clinical Outcome Assessments (eCOA) In Clinical Trials
Manual outcome tracking creates compliance gaps and data quality risks. Electronic assessments help trial teams capture cleaner data, faster.